nerve agents

43
1 LPC/CBRN 24 Jan 06 C191W047/1 Nerve Agents Nerve Agents

Upload: larrylentino

Post on 18-Jan-2015

1.088 views

Category:

Education


1 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Nerve Agents

1LPC/CBRN 24 Jan 06 C191W047/1

Nerve AgentsNerve Agents

Page 2: Nerve Agents

2LPC/CBRN 24 Jan 06 C191W047/1

IntroductionIntroduction

Chemical weapons Chemical weapons have been around for have been around for decades.decades.

Nerve agents among Nerve agents among the most deadly.the most deadly.

Manufactured by Manufactured by simple techniques.simple techniques.

Raw materials are Raw materials are inexpensive and inexpensive and readily available.readily available.

Page 3: Nerve Agents

3LPC/CBRN 24 Jan 06 C191W047/1

Overview of Nerve AgentsOverview of Nerve Agents

Developed in Germany.Developed in Germany. Only known Only known

battlefield use is in battlefield use is in the Iran-Iraq the Iran-Iraq conflict.conflict.

Many countries Many countries have the technology have the technology to develop nerve to develop nerve agents.agents.

Terrorist attacks in Japan.Terrorist attacks in Japan.

Page 4: Nerve Agents

4LPC/CBRN 24 Jan 06 C191W047/1

Overview of Nerve AgentsOverview of Nerve Agents

Hazards in liquid and Hazards in liquid and vapor state.vapor state.

Dispersed from missiles, Dispersed from missiles, bombs, spray tanks, land bombs, spray tanks, land mines, and other mines, and other munitions.munitions.

Page 5: Nerve Agents

5LPC/CBRN 24 Jan 06 C191W047/1

Overview of Nerve AgentsOverview of Nerve Agents

Acetylcholine (ACh) is a Acetylcholine (ACh) is a neurotransmitter in the neurotransmitter in the nervous system.nervous system.

Acetylcholinesterase Acetylcholinesterase (AChE) (an enzyme) (AChE) (an enzyme) stops the action of Ach.stops the action of Ach.

Nerve agents bind to Nerve agents bind to AChE.AChE.

ACh builds up and ACh builds up and continues to act.continues to act.

Page 6: Nerve Agents

6LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh Transmission Nerve to Nerve Nerve to Nerve

ACh

Page 7: Nerve Agents

7LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh Transmission Nerve to Nerve Nerve to Nerve

ACh

Page 8: Nerve Agents

8LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh Transmission Nerve to Nerve Nerve to Nerve

ACh

Page 9: Nerve Agents

9LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh Transmission Nerve to Skeletal Muscle-Stimulation Nerve to Skeletal Muscle-Stimulation

Page 10: Nerve Agents

10

LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh TransmissionNerve to Smooth Muscle-StimulationNerve to Smooth Muscle-Stimulation

Page 11: Nerve Agents

11

LPC/CBRN 24 Jan 06 C191W047/1

Normal ACh TransmissionNormal ACh Transmission Nerve to Glands-Normal secretions Nerve to Glands-Normal secretions

Page 12: Nerve Agents

12

LPC/CBRN 24 Jan 06 C191W047/1

Impulse Termination: Impulse Termination: The Role of AChEThe Role of AChE

ACh

AChE

Page 13: Nerve Agents

13

LPC/CBRN 24 Jan 06 C191W047/1

Exposure to Nerve AgentExposure to Nerve Agent

ACh

AChE

Page 14: Nerve Agents

14

LPC/CBRN 24 Jan 06 C191W047/1

Exposure to Nerve Agent-Binds Exposure to Nerve Agent-Binds AChE- causing excessive AChE- causing excessive

stimulationstimulation

ACh

AChE

Page 15: Nerve Agents

15

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agents Effects: Nerve Agents Effects: Skeletal Muscle-Over stimulationSkeletal Muscle-Over stimulation

ACh

AChE

Page 16: Nerve Agents

16

LPC/CBRN 24 Jan 06 C191W047/1

Impulse Termination: Impulse Termination: The Role of AChE-The Role of AChE-Stops stimulationStops stimulation

ACh

AChE

Page 17: Nerve Agents

17

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agents Effects:Nerve Agents Effects: Smooth and Cardiac Muscle Smooth and Cardiac Muscle

ACh

AChE

Page 18: Nerve Agents

18

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agents Effects on Glands- Nerve Agents Effects on Glands- Increased SecretionsIncreased Secretions

ACh

AChE

Page 19: Nerve Agents

19

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agent CharacteristicsNerve Agent Characteristics

Liquid unless exposed Liquid unless exposed to extreme heat or cold.to extreme heat or cold.

Volatility.Volatility. Colorless to light Colorless to light

brown.brown. Odorless.Odorless. Routes of entry.Routes of entry.

Page 20: Nerve Agents

20

LPC/CBRN 24 Jan 06 C191W047/1

Levels of Exposure and Levels of Exposure and Clinical EffectsClinical Effects

Depends of dosage Depends of dosage and route of exposure.and route of exposure.

Vapor effects are Vapor effects are different than liquid different than liquid effects.effects.

Page 21: Nerve Agents

21

LPC/CBRN 24 Jan 06 C191W047/1

Level of Exposure - MildLevel of Exposure - Mild

VaporVapor::

– Causes effects in eyes, Causes effects in eyes,

nose and lungs- local nose and lungs- local

and/or systemic effectand/or systemic effect LiquidLiquid::

– Systemic Systemic

gastrointestinal effectgastrointestinal effect

Page 22: Nerve Agents

22

LPC/CBRN 24 Jan 06 C191W047/1

Level of Exposure - MildLevel of Exposure - Mild

Rhinorrhea - may be Rhinorrhea - may be

the first sign.the first sign. Frontal headache/eye Frontal headache/eye

pain.pain. Difficulty in seeing.Difficulty in seeing. Tightness in chest.Tightness in chest.

Page 23: Nerve Agents

23

LPC/CBRN 24 Jan 06 C191W047/1

Level of Exposure - MildLevel of Exposure - Mild

Difficulty breathing.Difficulty breathing. Drooling.Drooling. Localized sweating.Localized sweating. Muscle twitching.Muscle twitching.

Page 24: Nerve Agents

24

LPC/CBRN 24 Jan 06 C191W047/1

Level of Exposure - SevereLevel of Exposure - Severe The signs and symptoms of mild nerve The signs and symptoms of mild nerve

agent exposure may occur plus:agent exposure may occur plus: Nausea, vomiting, diarrheaNausea, vomiting, diarrhea Severe muscle twitchingSevere muscle twitching SeizuresSeizures Loss of bladder and bowel controlLoss of bladder and bowel control Confused behavior, followed by LOCConfused behavior, followed by LOC Respiratory failure > deathRespiratory failure > death

Page 25: Nerve Agents

25

LPC/CBRN 24 Jan 06 C191W047/1

Time Interval of EffectsTime Interval of Effects VaporVapor: seconds to : seconds to

minutes. No delay minutes. No delay period.period.

Liquid: delay in Liquid: delay in symptoms 1-30 symptoms 1-30 minutes. Small liquid minutes. Small liquid exposure - symptoms exposure - symptoms up to 18 hours.up to 18 hours.

Page 26: Nerve Agents

26

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Self-AidTreatment Steps: Self-Aid Protect yourself - put on your protective mask.Protect yourself - put on your protective mask. Give the alarm.Give the alarm. Perform a hasty Perform a hasty

self-evaluation.self-evaluation. Administer antidote if Administer antidote if

signs and symptoms signs and symptoms are noted: are noted:

Page 27: Nerve Agents

27

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Self-AidTreatment Steps: Self-Aid Use one MARK I Nerve Agent Antidote Kit Use one MARK I Nerve Agent Antidote Kit

(NAAK):(NAAK):

Use one Antidote Treatment, Nerve Agent Use one Antidote Treatment, Nerve Agent Auto-injector (ATNAA): Auto-injector (ATNAA):

Page 28: Nerve Agents

28

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Self-AidTreatment Steps: Self-Aid

Never administer more than one NAAK Never administer more than one NAAK or ATNAA to yourself.or ATNAA to yourself.

If you needed more than one NAAK/ If you needed more than one NAAK/ ATNAA, you would be too incapacitated ATNAA, you would be too incapacitated to know it.to know it.

Page 29: Nerve Agents

29

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Self-AidTreatment Steps: Self-Aid

Decontaminate skin if Decontaminate skin if necessary.necessary.

Put on protective clothing Put on protective clothing (MOPP level 4).(MOPP level 4).

Seek buddy-aid or Seek buddy-aid or medical care.medical care.

JSLISTJSLIST

Page 30: Nerve Agents

30

LPC/CBRN 24 Jan 06 C191W047/1

Mark I NAAKMark I NAAK Includes:Includes:

– Atropine 2mgAtropine 2mg - blocks effects of acetylcholine - blocks effects of acetylcholine and produces symptom relief.and produces symptom relief.

– 2-PAM-Cl 600 mg2-PAM-Cl 600 mg - blocks transmission of - blocks transmission of nerve agent.nerve agent.

Page 31: Nerve Agents

31

LPC/CBRN 24 Jan 06 C191W047/1

ATNAAATNAA Includes:Includes:

– Atropine 2.1 mgAtropine 2.1 mg..– 2-PAM-Cl 600 mg2-PAM-Cl 600 mg..

Page 32: Nerve Agents

32

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Buddy-AidTreatment Steps: Buddy-Aid

Protect yourself; then:Protect yourself; then:– Mask the casualtyMask the casualty– Check casualty and surrounding area for Check casualty and surrounding area for

expended auto-injectorsexpended auto-injectors– Administer total of 3 MARK I NAAK/ATNAA; Administer total of 3 MARK I NAAK/ATNAA;

use the casualties’ sets.use the casualties’ sets.

Page 33: Nerve Agents

33

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Buddy-AidTreatment Steps: Buddy-Aid Protect yourself (cont’d):Protect yourself (cont’d):

– Administer 1 Convulsant Administer 1 Convulsant Antidote for Nerve Agent Antidote for Nerve Agent (CANA) injector (CANA) injector

– Decontaminate the Decontaminate the casualtycasualty

– Assess effectiveness of Assess effectiveness of treatment (atropinization treatment (atropinization and cessation of and cessation of convulsions)convulsions)

Page 34: Nerve Agents

34

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Buddy-AidTreatment Steps: Buddy-Aid

Additional atropine can be given at Additional atropine can be given at 15 minute 15 minute intervalsintervals until signs of nerve agent poisoning until signs of nerve agent poisoning decrease:decrease:– Heart rate is above 90 beats per minuteHeart rate is above 90 beats per minute– Bronchial secretions are reducedBronchial secretions are reduced– Salivation is reducedSalivation is reduced

Page 35: Nerve Agents

35

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Buddy-AidTreatment Steps: Buddy-Aid

Additional CANA, up to a total of 3, can be Additional CANA, up to a total of 3, can be given at given at 5 to 10 minute intervals5 to 10 minute intervals if convulsions if convulsions persistpersist

Page 36: Nerve Agents

36

LPC/CBRN 24 Jan 06 C191W047/1

CANA InjectorCANA Injector

Contains diazepam (anti-Contains diazepam (anti-seizure medication).seizure medication).

Given to all casualties Given to all casualties requiring 3 MARK I sets.requiring 3 MARK I sets.

Soldier medic may carry Soldier medic may carry extra CANA injectors and extra CANA injectors and may give additional may give additional CANA injectors in a CANA injectors in a seizing casualty.seizing casualty.

Page 37: Nerve Agents

37

LPC/CBRN 24 Jan 06 C191W047/1

Treatment Steps: Buddy-AidTreatment Steps: Buddy-Aid

Secure used injectors to the Secure used injectors to the casualty’s upper left pocket casualty’s upper left pocket flap of the BDO; flap of the BDO; left pocket on the sleeve of left pocket on the sleeve of the JSLIST. the JSLIST.

Record all treatment given Record all treatment given on the casualty’s FMC. on the casualty’s FMC.

Evacuate and provide Evacuate and provide assisted ventilations, if assisted ventilations, if necessary.necessary.

Page 38: Nerve Agents

38

LPC/CBRN 24 Jan 06 C191W047/1

Side Effects of AtropineSide Effects of Atropine

MildMild: dry mouth, skin : dry mouth, skin flushing, drowsiness, flushing, drowsiness, decreased combat decreased combat performance.performance.

SevereSevere: drowsiness, : drowsiness, fatigue, visual blurring, fatigue, visual blurring, increased heat injury increased heat injury risk.risk.

Page 39: Nerve Agents

39

LPC/CBRN 24 Jan 06 C191W047/1

Medication Side EffectsMedication Side Effects

2-PAM-Cl2-PAM-Cl::Mild visual changesMild visual changes

CANACANA::

Decreased combat Decreased combat performanceperformance

Page 40: Nerve Agents

40

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agent PretreatmentNerve Agent Pretreatment

1990 (Gulf War I), US 1990 (Gulf War I), US military fields military fields pyridostigmine bromide pyridostigmine bromide (NAPP) as a pretreatment (NAPP) as a pretreatment for nerve agent exposure.for nerve agent exposure.

NOT an antidote - not NOT an antidote - not taken taken afterafter exposure. exposure.

Mild side effects.Mild side effects.

Page 41: Nerve Agents

41

LPC/CBRN 24 Jan 06 C191W047/1

Nerve Agent PretreatmentNerve Agent Pretreatment

Medication to be Medication to be taken at least taken at least 8 hours 8 hours prior to exposureprior to exposure..

Service members Service members issued one NAPP in issued one NAPP in high risk areas.high risk areas.

Chain of command Chain of command issues orders to start issues orders to start the NAPP.the NAPP.

Page 42: Nerve Agents

42

LPC/CBRN 24 Jan 06 C191W047/1

SummarySummary

Nerve Agent Nerve Agent

CharacteristicsCharacteristics

Signs and Symptoms Signs and Symptoms

of Nerve Agent of Nerve Agent

ExposureExposure

Treatment StepsTreatment Steps

Nerve Agent Nerve Agent

PretreatmentPretreatment

Page 43: Nerve Agents

43

LPC/CBRN 24 Jan 06 C191W047/1

Questions?Questions?